SEATTLE, April 07, 2021, (MEDGADGET) — Global Non-invasive Pain Management Devices Market Overview
Non-invasive pain management is a procedure followed to reduce pain caused by an illness or injury. Increasing incidences of cancer, coupled with rising number of trauma cases worldwide leads to a higher demand for non-invasive pain management devices. Pain management is broadly classified as non-invasive non-drug pain management, non-invasive pharmacologic pain management, and invasive pain management. The non-invasive non-drug pain management process, in particular, involves specific exercise regimes; manual techniques involving force techniques for the affected area; and behavioral modification, including cognitive therapy, superficial heating and cooling of skin, and the use of electrotherapy devices. The greatest advantage with non-invasive pain management is that it involves a holistic approach to treatment, focuses on long-term solutions to cure the root causes, and fosters the body’s self-healing process. As per the statistics released by the Centers for Disease Control and Prevention (CDC) in 2014, mental trauma accounts for around 41 million visits to the emergency wards each year in the U.S. The most commonly used non-invasive pain management devices include Orbasone Pain Relief System (Orthometrix Inc.), Medio UniSono eco (Iskra Medical), Medio MULTI eco (Iskra Medical), ActivBody, Apostherapy (Sportsmed), VitalStim Plus (DJO Global).
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/106
Supportive Government Initiative are a much needed impetus for the global non-invasive pain management devices market growth
Developed economies of the world, such as the U.S., the U.K. and Germany, experience a high rate of adoption of non-invasive pain management devices, due to better healthcare facilities and easy availability in these countries. According to the American Academy of Pain Medicine, around 100 million people are reported to be from chronic pain, 25.8 million from diabetes, 16.3 million from coronary heart diseases, and about 11.9 million from cancer in the U.S. every year. This number is expected to further increase in the near future. The increasing geriatric population, rising prevalence of spinal cord injuries and multiple sclerosis, as well as growing number of trauma cases are predicted to favor the global non-invasive pain management devices market expansion. Growing funding initiatives by various governments and non-governmental organizations, such as the National Institutes of Health (NIH) and Brain Research through Advancing Innovative Neurotechnologies (BRAIN), aimed to better understand the human brain and harness the same for various therapeutic applications, including effective pain management, is another significant factor expected to create a conducive environment for the global market growth. Such initiatives are also believed to encourage collaborations between neurologists and scientists across the globe to accelerate the development and application of various technologies in this space.
In March 2016, the National Pain Strategy was released by the Office of the Assistant Secretary for Health (OASH) at the U.S. department of Health and Human Services (HHS). It includes a plethora of benefits for people suffering from chronic pain, which in turn, is expected to bring about a decline in the prevalence of injuries and illnesses in the pediatric and geriatric populations. This is therefore likely to provide an impetus to the global non-invasive pain management devices market growth.
Global Non-invasive Pain Management Devices Market – Competitive Landscape
The global non-invasive pain management devices market is highly fragmented, owing to the participation of many established and emerging players. These players are deeply inclined towards introducing new, user-friendly applications to diagnose various symptoms of chronic pain. Iskra Medical d.o.o, ActivLife Technologies Pty Ltd, Chattanooga International, Zynex Medical, I-Tech Medical Division, and MediHighTec are some of the leading companies operating in the global market.
Growing focus on development of drug-free treatment options
Several companies are focusing on launching new devices, with advanced features and technologies, in a bid to differentiate their products from those of their competitors. For instance, in July 2016, Bayer launched Aleve Direct Therapy TENS Device—a safe, drug free and pain relief device meant for professional use. The device is used to provide temporary relief from pain associated with sore and aching muscles. The non-invasive pain management devices market is projected to witness robust growth due to increasing chronic pain cases as projected by the WHO in 2015, that around 20% of the adult population in Europe suffered from chronic pain and around 16% population of the U.S. suffered from chronic and severe pain. Furthermore, the Australian government, after receiving approval by the multidisciplinary faculty of pain medicine, brought forward an initiative to achieve better pain management facilities in the country for patients suffering from cancer.
Increasing number of product approvals for non-invasive pain management devices is expected to drive the global non-invasive pain management devices market growth over the forecast period. For instance, in 2017, the U.S. Food and Drug Administration (FDA) cleared Xavant Technology’s non-invasive neuromodulation device, called Stimpod NMS460, which was designed to provide relief from chronic intractable pain.
Moreover, continuous research and analysis of non-invasive pain treatment devices is expected to generate considerable demand and adoption of these devices. In April 2019, researchers from the University of Rome Tor Vergata, Rome, Italy reviewed the efficacy of the Scrambler therapy (ST), which is an electro-analgesia therapy for the non-invasive treatment of chronic neuropathic and cancer pain. The review was aimed at clarifying the underlying mechanisms of the therapy, and create awareness regarding its appropriate usage to increase its effectiveness. Furthermore, Tivic Health Systems, maker of a commercial sinus pain relief device, announced that the company had raised $8 million in seed funding in July 2019. The company announced that it would be utilizing this funding for the market launch of its ClearUP device.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/106
Global Non-invasive Pain Management Devices Market Taxonomy
The global non-invasive pain management devices market is classified on the basis of the following segments:
- Product Type:
- Electrical Stimulation Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Neuromuscular Electrical Stimulation (NMES/EMS) Devices
- Trigeminal Nerve Stimulation (TNS)
- Transcranial magnetic stimulation (TMS)
- Combination Devices
- Neuropathic Pain
- Cancer Pain
- Facial & Migraine Pain
- Musculoskeletal Pain
- End Users:
- Specialized Clinics
- Ambulatory Surgical Centers
- Long-term care centers
- Electrical Stimulation Devices
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027